Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2022-12-13 00:00:00 ET · period of report 2022-12-09 · accession 0001883850-22-000123 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-12-13 | 2022-12-09 | REGN | McCourt Marion | EVP Commercial | F - Tax | $753.28 | -274 | 19.4K | -1% | -$206.4K | |
| 2022-12-13 | 2022-12-12 | REGN | McCourt Marion | EVP Commercial | S - Sale | $730.17 | -264 | 19.1K | -1% | -$192.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-09 | F | D | 274 | $753.28 | 19,370 | D | — | — | |
| 2 | Common | Common Stock | 2022-12-12 | S | D | 264 | $730.17 | 19,106 | D | — | — |